Hi-Tech Pharmacal (HITK) Gets FDA Approval for Generic Lorazepam Intensol ANDA

Hi-Tech Pharmacal Co., Inc. (Nasdaq: HITK), reports that the US Food and Drug Administration, (FDA) granted final approval for the Company's Abbreviated New Drug Application, (ANDA) for Lorazepam oral concentrate 2mg/mL, the generic for Roxanne’s Lorazepam Intensol oral concentrate which had combined brand and generic sales of $10 million for the 12 months ended December 2011 according to IMS sales data. The product is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Hi-Tech plans to launch the product by May 2012.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Revolution Medicines prices RASONQUE at $39,800 per month
• Arcline completes all-cash acquisition of AstroNova at $29 per share
• FDA approves Revolution Medicines pancreatic cancer drug Rasonque